Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 347

1.

Functional involvement of human periaqueductal gray and other midbrain nuclei in cognitive control.

Kragel PA, Bianciardi M, Hartley L, Matthewson G, Choi JK, Quigley KS, Wald LL, Wager TD, Barrett LF, Satpute AB.

J Neurosci. 2019 Jun 3. pii: 2043-18. doi: 10.1523/JNEUROSCI.2043-18.2019. [Epub ahead of print]

PMID:
31160537
2.

Investigating the Feasibility of Brief Compassion Focused Therapy in Individuals in Treatment for Opioid Use Disorder.

Carlyle M, Rockliff H, Edwards R, Ene C, Karl A, Marsh B, Hartley L, Morgan CJ.

Subst Abuse. 2019 Apr 2;13:1178221819836726. doi: 10.1177/1178221819836726. eCollection 2019.

3.

Retinal microvascular development in the first two years.

Kandasamy Y, Rudd D, Smith R, Hartley L, De Boever P.

Microvasc Res. 2019 Sep;125:103875. doi: 10.1016/j.mvr.2019.04.005. Epub 2019 Apr 11.

PMID:
30981745
4.

Mediterranean-style diet for the primary and secondary prevention of cardiovascular disease.

Rees K, Takeda A, Martin N, Ellis L, Wijesekara D, Vepa A, Das A, Hartley L, Stranges S.

Cochrane Database Syst Rev. 2019 Mar 13;3:CD009825. doi: 10.1002/14651858.CD009825.pub3.

PMID:
30864165
5.

A concurrent pictorial drug choice task marks multiple risk factors in treatment-engaged smokers and drinkers.

Hardy L, Parker S, Hartley L, Hogarth L.

Behav Pharmacol. 2018 Dec;29(8):716-725. doi: 10.1097/FBP.0000000000000421.

PMID:
30169375
6.

Intact goal-directed control in treatment-seeking drug users indexed by outcome-devaluation and Pavlovian to instrumental transfer: critique of habit theory.

Hogarth L, Lam-Cassettari C, Pacitti H, Currah T, Mahlberg J, Hartley L, Moustafa A.

Eur J Neurosci. 2018 May 22. doi: 10.1111/ejn.13961. [Epub ahead of print]

PMID:
29787620
7.

Acetazolamide can improve symptoms and signs in ion channel-related congenital myopathy.

Matthews E, Hartley L, Sud R, Hanna MG, Muntoni F, Munot P.

J Neurol Neurosurg Psychiatry. 2019 Feb;90(2):243-245. doi: 10.1136/jnnp-2017-317849. Epub 2018 May 16. No abstract available.

PMID:
29769250
8.

Rhabdomyolysis in Stuve-Wiedemann syndrome.

Ramdeny PS, Powell C, Chakraborty M, Hartley L.

BMJ Case Rep. 2018 Feb 8;2018. pii: bcr-2017-222863. doi: 10.1136/bcr-2017-222863.

PMID:
29437806
9.

WITHDRAWN: Transcendental meditation for the primary prevention of cardiovascular disease.

Hartley L, Mavrodaris A, Flowers N, Ernst E, Rees K.

Cochrane Database Syst Rev. 2017 Nov 15;11:CD010359. doi: 10.1002/14651858.CD010359.pub3. Review.

10.

Whole grain cereals for the primary or secondary prevention of cardiovascular disease.

Kelly SA, Hartley L, Loveman E, Colquitt JL, Jones HM, Al-Khudairy L, Clar C, Germanò R, Lunn HR, Frost G, Rees K.

Cochrane Database Syst Rev. 2017 Aug 24;8:CD005051. doi: 10.1002/14651858.CD005051.pub3. Review.

11.

Low glycaemic index diets for the prevention of cardiovascular disease.

Clar C, Al-Khudairy L, Loveman E, Kelly SA, Hartley L, Flowers N, Germanò R, Frost G, Rees K.

Cochrane Database Syst Rev. 2017 Jul 31;7:CD004467. doi: 10.1002/14651858.CD004467.pub3. Review.

12.

The lack of association between vascular endothelial growth factor and retinopathy of prematurity in an observational study.

Kandasamy Y, Hartley L, Rudd D, Smith R.

J Matern Fetal Neonatal Med. 2018 Aug;31(16):2202-2208. doi: 10.1080/14767058.2017.1338261. Epub 2017 Jun 20.

PMID:
28573924
13.

Vitamin C supplementation for the primary prevention of cardiovascular disease.

Al-Khudairy L, Flowers N, Wheelhouse R, Ghannam O, Hartley L, Stranges S, Rees K.

Cochrane Database Syst Rev. 2017 Mar 16;3:CD011114. doi: 10.1002/14651858.CD011114.pub2. Review.

14.

Exploring physical activity engagement and barriers for asylum seekers in Australia coping with prolonged uncertainty and no right to work.

Hartley L, Fleay C, Tye ME.

Health Soc Care Community. 2017 May;25(3):1190-1198. doi: 10.1111/hsc.12419. Epub 2017 Jan 30.

PMID:
28138985
15.

Retinal microvascular plasticity in a premature neonate.

Kandasamy Y, Hartley L, Smith R.

J Dev Orig Health Dis. 2017 Jun;8(3):284-286. doi: 10.1017/S2040174416000817. Epub 2017 Jan 31.

PMID:
28137344
16.

Crossing the Threshold: Bringing Biological Variation to the Foreground.

Batzli JM, Knight JK, Hartley LM, Maskiewicz AC, Desy EA.

CBE Life Sci Educ. 2016 winter;15(4). pii: es9.

17.

Aphasia rehabilitation during adolescence: a case report.

Laures-Gore J, McCusker T, Hartley LL.

Disabil Rehabil. 2017 Jun;39(12):1235-1242. doi: 10.1080/09638288.2016.1191550. Epub 2016 Aug 18.

PMID:
27538892
18.

Multiple Risk Factor Interventions for Primary Prevention of CVD in LMIC: A Cochrane Review.

Uthman OA, Hartley L, Rees K, Taylor F, Ebrahim S, Clarke A.

Glob Heart. 2017 Sep;12(3):199-208.e8. doi: 10.1016/j.gheart.2016.03.639. Epub 2016 Jul 21. Review.

19.

The association between systemic vascular endothelial growth factor and retinopathy of prematurity in premature infants: a systematic review.

Kandasamy Y, Hartley L, Rudd D, Smith R.

Br J Ophthalmol. 2017 Jan;101(1):21-24. doi: 10.1136/bjophthalmol-2016-308828. Epub 2016 Jul 7. Review.

PMID:
27388246
20.

Headache meets neurology and psychiatry: a framework for diagnosis.

Haddad N, McMinn B, Hartley L.

Arch Dis Child Educ Pract Ed. 2016 Aug;101(4):200-5. doi: 10.1136/archdischild-2015-309066. Epub 2016 May 25.

PMID:
27225011
21.

Pathogenic copy number variants and SCN1A mutations in patients with intellectual disability and childhood-onset epilepsy.

Fry AE, Rees E, Thompson R, Mantripragada K, Blake P, Jones G, Morgan S, Jose S, Mugalaasi H, Archer H, McCann E, Clarke A, Taylor C, Davies S, Gibbon F, Te Water Naude J, Hartley L, Thomas G, White C, Natarajan J, Thomas RH, Drew C, Chung SK, Rees MI, Holmans P, Owen MJ, Kirov G, Pilz DT, Kerr MP.

BMC Med Genet. 2016 Apr 26;17(1):34. doi: 10.1186/s12881-016-0294-2.

22.

Distal hereditary motor neuropathy with vocal cord paresis: from difficulty in choral singing to a molecular genetic diagnosis.

Ingram G, Barwick KE, Hartley L, McEntagart M, Crosby AH, Llewelyn G, Morris HR.

Pract Neurol. 2016 Jun;16(3):247-51. doi: 10.1136/practneurol-2015-001307. Epub 2016 Jan 19.

PMID:
26786006
23.

Dietary fibre for the primary prevention of cardiovascular disease.

Hartley L, May MD, Loveman E, Colquitt JL, Rees K.

Cochrane Database Syst Rev. 2016 Jan 7;(1):CD011472. doi: 10.1002/14651858.CD011472.pub2. Review.

PMID:
26758499
24.

Loss-of-function mutations in SCN4A cause severe foetal hypokinesia or 'classical' congenital myopathy.

Zaharieva IT, Thor MG, Oates EC, van Karnebeek C, Hendson G, Blom E, Witting N, Rasmussen M, Gabbett MT, Ravenscroft G, Sframeli M, Suetterlin K, Sarkozy A, D'Argenzio L, Hartley L, Matthews E, Pitt M, Vissing J, Ballegaard M, Krarup C, Slørdahl A, Halvorsen H, Ye XC, Zhang LH, Løkken N, Werlauff U, Abdelsayed M, Davis MR, Feng L, Phadke R, Sewry CA, Morgan JE, Laing NG, Vallance H, Ruben P, Hanna MG, Lewis S, Kamsteeg EJ, Männikkö R, Muntoni F.

Brain. 2016 Mar;139(Pt 3):674-91. doi: 10.1093/brain/awv352. Epub 2015 Dec 22.

25.

Omega 6 fatty acids for the primary prevention of cardiovascular disease.

Al-Khudairy L, Hartley L, Clar C, Flowers N, Hooper L, Rees K.

Cochrane Database Syst Rev. 2015 Nov 16;(11):CD011094. doi: 10.1002/14651858.CD011094.pub2. Review. Update in: Cochrane Database Syst Rev. 2018 Jul 18;7:CD011094.

PMID:
26571451
26.

Cochrane corner: oral hormone therapy and cardiovascular outcomes in post-menopausal women.

Boardman H, Hartley L, Eisinga A, Main C, Figuls MR.

Heart. 2016 Jan;102(1):9-11. doi: 10.1136/heartjnl-2015-308287. Epub 2015 Oct 9. Review. No abstract available.

PMID:
26453279
27.

Nut consumption for the primary prevention of cardiovascular disease.

Martin N, Germanò R, Hartley L, Adler AJ, Rees K.

Cochrane Database Syst Rev. 2015 Sep 28;(9):CD011583. doi: 10.1002/14651858.CD011583.pub2. Review.

PMID:
26411417
28.

Vitamin K for the primary prevention of cardiovascular disease.

Hartley L, Clar C, Ghannam O, Flowers N, Stranges S, Rees K.

Cochrane Database Syst Rev. 2015 Sep 21;(9):CD011148. doi: 10.1002/14651858.CD011148.pub2. Review.

PMID:
26389791
29.

Multiple risk factor interventions for primary prevention of cardiovascular disease in low- and middle-income countries.

Uthman OA, Hartley L, Rees K, Taylor F, Ebrahim S, Clarke A.

Cochrane Database Syst Rev. 2015 Aug 4;(8):CD011163. doi: 10.1002/14651858.CD011163.pub2. Review.

30.

Retention on anti-tumour necrosis factor therapy: the Waikato experience.

Ip K, Hartley L, Solanki K, White D.

N Z Med J. 2015 May 29;128(1415):34-40.

PMID:
26117510
31.

Qigong for the primary prevention of cardiovascular disease.

Hartley L, Lee MS, Kwong JS, Flowers N, Todkill D, Ernst E, Rees K.

Cochrane Database Syst Rev. 2015 Jun 11;(6):CD010390. doi: 10.1002/14651858.CD010390.pub2. Review.

PMID:
26068956
32.

Effect of the angiotensin-receptor-neprilysin inhibitor LCZ696 compared with enalapril on mode of death in heart failure patients.

Desai AS, McMurray JJ, Packer M, Swedberg K, Rouleau JL, Chen F, Gong J, Rizkala AR, Brahimi A, Claggett B, Finn PV, Hartley LH, Liu J, Lefkowitz M, Shi V, Zile MR, Solomon SD.

Eur Heart J. 2015 Aug 7;36(30):1990-7. doi: 10.1093/eurheartj/ehv186. Epub 2015 May 28.

PMID:
26022006
33.

Cause of Death in Patients With Diabetic CKD Enrolled in the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT).

Charytan DM, Lewis EF, Desai AS, Weinrauch LA, Ivanovich P, Toto RD, Claggett B, Liu J, Hartley LH, Finn P, Singh AK, Levey AS, Pfeffer MA, McMurray JJ, Solomon SD.

Am J Kidney Dis. 2015 Sep;66(3):429-40. doi: 10.1053/j.ajkd.2015.02.324. Epub 2015 Apr 29.

34.

Hormone therapy for preventing cardiovascular disease in post-menopausal women.

Boardman HM, Hartley L, Eisinga A, Main C, Roqué i Figuls M, Bonfill Cosp X, Gabriel Sanchez R, Knight B.

Cochrane Database Syst Rev. 2015 Mar 10;(3):CD002229. doi: 10.1002/14651858.CD002229.pub4. Review.

PMID:
25754617
35.

A multistudy analysis investigating systematic differences in cardiovascular trial results between Europe and Asia.

Hartley LC, Girling AJ, Bowater RJ, Lilford RJ.

J Epidemiol Community Health. 2015 Apr;69(4):397-404. doi: 10.1136/jech-2013-203646. Epub 2014 Dec 5. Review.

PMID:
25480408
36.

Co-enzyme Q10 supplementation for the primary prevention of cardiovascular disease.

Flowers N, Hartley L, Todkill D, Stranges S, Rees K.

Cochrane Database Syst Rev. 2014;(12):CD010405. doi: 10.1002/14651858.CD010405.pub2. Epub 2014 Dec 4. Review.

PMID:
25474484
37.

Transcendental meditation for the primary prevention of cardiovascular disease.

Hartley L, Mavrodaris A, Flowers N, Ernst E, Rees K.

Cochrane Database Syst Rev. 2014;(12):CD010359. doi: 10.1002/14651858.CD010359.pub2. Epub 2014 Dec 1. Review. Update in: Cochrane Database Syst Rev. 2017 Nov 15;11:CD010359.

PMID:
25436436
38.

Dual roles for Id4 in the regulation of estrogen signaling in the mammary gland and ovary.

Best SA, Hutt KJ, Fu NY, Vaillant F, Liew SH, Hartley L, Scott CL, Lindeman GJ, Visvader JE.

Development. 2014 Aug;141(16):3159-64. doi: 10.1242/dev.108498. Epub 2014 Jul 18.

39.

The effects of black-tailed prairie dogs on plant communities within a complex urban landscape: an ecological surprise?

Beals SC, Hartley LM, Prevéy JS, Seastedt TR.

Ecology. 2014 May;95(5):1349-59.

PMID:
25000766
40.

Are cardiovascular trial results systematically different between North America and Europe? A study based on intra-meta-analysis comparisons.

Bowater RJ, Hartley LC, Lilford RJ.

Arch Cardiovasc Dis. 2015 Jan;108(1):23-38. doi: 10.1016/j.acvd.2014.03.005. Epub 2014 Jul 2. Review.

41.

Implementing shared governance in a patient care support industry: information technology leading the way.

Hartley LA.

J Nurs Adm. 2014 Jun;44(6):315-7. doi: 10.1097/NNA.0000000000000074.

PMID:
24853793
42.

Yoga for the primary prevention of cardiovascular disease.

Hartley L, Dyakova M, Holmes J, Clarke A, Lee MS, Ernst E, Rees K.

Cochrane Database Syst Rev. 2014 May 13;(5):CD010072. doi: 10.1002/14651858.CD010072.pub2. Review.

PMID:
24825181
43.

The effect of erythropoietin on the severity of retinopathy of prematurity.

Kandasamy Y, Kumar P, Hartley L.

Eye (Lond). 2014 Jul;28(7):814-8. doi: 10.1038/eye.2014.95. Epub 2014 Apr 25.

44.

Tai chi for primary prevention of cardiovascular disease.

Hartley L, Flowers N, Lee MS, Ernst E, Rees K.

Cochrane Database Syst Rev. 2014 Apr 9;(4):CD010366. doi: 10.1002/14651858.CD010366.pub2. Review.

PMID:
24715694
45.

Molecular correlates of platinum response in human high-grade serous ovarian cancer patient-derived xenografts.

Topp MD, Hartley L, Cook M, Heong V, Boehm E, McShane L, Pyman J, McNally O, Ananda S, Harrell M, Etemadmoghadam D, Galletta L, Alsop K, Mitchell G, Fox SB, Kerr JB, Hutt KJ, Kaufmann SH, Australian Ovarian Cancer Study, Swisher EM, Bowtell DD, Wakefield MJ, Scott CL.

Mol Oncol. 2014 May;8(3):656-68. doi: 10.1016/j.molonc.2014.01.008. Epub 2014 Jan 24.

46.

'Mediterranean' dietary pattern for the primary prevention of cardiovascular disease.

Rees K, Hartley L, Flowers N, Clarke A, Hooper L, Thorogood M, Stranges S.

Cochrane Database Syst Rev. 2013 Aug 12;(8):CD009825. doi: 10.1002/14651858.CD009825.pub2. Review. Update in: Cochrane Database Syst Rev. 2019 Mar 13;3:CD009825.

PMID:
23939686
47.

Belimumab: a technological advance for systemic lupus erythematosus patients? Report of a systematic review and meta-analysis.

Kandala NB, Connock M, Grove A, Sutcliffe P, Mohiuddin S, Hartley L, Court R, Cummins E, Gordon C, Clarke A.

BMJ Open. 2013 Jul 19;3(7). pii: e002852. doi: 10.1136/bmjopen-2013-002852. Print 2013.

48.

Green and black tea for the primary prevention of cardiovascular disease.

Hartley L, Flowers N, Holmes J, Clarke A, Stranges S, Hooper L, Rees K.

Cochrane Database Syst Rev. 2013 Jun 18;(6):CD009934. doi: 10.1002/14651858.CD009934.pub2. Review.

PMID:
23780706
49.

Increased consumption of fruit and vegetables for the primary prevention of cardiovascular diseases.

Hartley L, Igbinedion E, Holmes J, Flowers N, Thorogood M, Clarke A, Stranges S, Hooper L, Rees K.

Cochrane Database Syst Rev. 2013 Jun 4;(6):CD009874. doi: 10.1002/14651858.CD009874.pub2. Review.

50.

Early neurodevelopmental assessment in Duchenne muscular dystrophy.

Pane M, Scalise R, Berardinelli A, D'Angelo G, Ricotti V, Alfieri P, Moroni I, Hartley L, Pera MC, Baranello G, Catteruccia M, Casalino T, Romeo DM, Graziano A, Gandioli C, Bianco F, Mazzone ES, Lombardo ME, Scoto M, Sivo S, Palermo C, Gualandi F, Sormani MP, Ferlini A, Bertini E, Muntoni F, Mercuri E.

Neuromuscul Disord. 2013 Jun;23(6):451-5. doi: 10.1016/j.nmd.2013.02.012. Epub 2013 Mar 25.

PMID:
23535446

Supplemental Content

Loading ...
Support Center